fluticasone propionate and salmeterol
Generic: fluticasone propionate and salmeterol
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
fluticasone propionate and salmeterol
Generic Name
fluticasone propionate and salmeterol
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
POWDER, METERED
Routes
Active Ingredients
fluticasone propionate 55 ug/1, salmeterol xinafoate 14 ug/1
Manufacturer
Identifiers & Regulatory
Product NDC
0093-3607
Product ID
0093-3607_f09e7a41-3e53-48b2-ab31-a249f4fb28ca
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA208799
Listing Expiration
2026-12-31
Marketing Start
2017-04-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00933607
Hyphenated Format
0093-3607
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fluticasone propionate and salmeterol (source: ndc)
Generic Name
fluticasone propionate and salmeterol (source: ndc)
Application Number
NDA208799 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 55 ug/1
- 14 ug/1
Packaging
- 1 POUCH in 1 CARTON (0093-3607-82) / 1 INHALER in 1 POUCH / 60 POWDER, METERED in 1 INHALER
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "f09e7a41-3e53-48b2-ab31-a249f4fb28ca", "openfda": {"unii": ["6EW8Q962A5", "O2GMZ0LF5W"], "rxcui": ["1918194", "1918203", "1918209"], "spl_set_id": ["43a27267-2f2b-410d-9c30-9cb95f35d9a1"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (0093-3607-82) / 1 INHALER in 1 POUCH / 60 POWDER, METERED in 1 INHALER", "package_ndc": "0093-3607-82", "marketing_start_date": "20170428"}], "brand_name": "Fluticasone Propionate and Salmeterol", "product_id": "0093-3607_f09e7a41-3e53-48b2-ab31-a249f4fb28ca", "dosage_form": "POWDER, METERED", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "0093-3607", "generic_name": "Fluticasone Propionate and Salmeterol", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluticasone Propionate and Salmeterol", "active_ingredients": [{"name": "FLUTICASONE PROPIONATE", "strength": "55 ug/1"}, {"name": "SALMETEROL XINAFOATE", "strength": "14 ug/1"}], "application_number": "NDA208799", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20170428", "listing_expiration_date": "20261231"}